Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis

Experimental Eye Research

Volumn 134, Issue , 2015, Pages 24-32

  Gimenes, Alexandre D ^a   Andrade, Teresa Raquel M ^a   Mello, Cláudia B ^b   Ramos, Lisandra ^a   Gil, Cristiane D ^a   Oliani, Sonia M ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Eosinophils; ERK; Lipocortin 1; Mast cells; Ocular allergy; Th1 Th2 cytokines

Indexed keywords

AC 2 26; ANTIINFLAMMATORY AGENT; DEXAMETHASONE; EOTAXIN; EYE DROPS; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; LIPOCORTIN 1; OVALBUMIN; PEPTIDE DERIVATIVE; RANTES; UNCLASSIFIED DRUG; ANNEXIN A1 PEPTIDE (2-26); CYTOKINE; GLUCOCORTICOID; PEPTIDE;

ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMOSIS; COMPARATIVE STUDY; CONJUNCTIVA; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; EOSINOPHIL; EXPERIMENTAL EYE DISEASE; EYE INFLAMMATION; EYELID EDEMA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MALE; MAST CELL DEGRANULATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CONJUNCTIVITIS, ALLERGIC; DISEASE MODEL; ENZYME IMMUNOASSAY; KNOCKOUT MOUSE; MAST CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; ANNEXIN A1; BLOTTING, WESTERN; CONJUNCTIVITIS, ALLERGIC; CYTOKINES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; EOSINOPHILS; GLUCOCORTICOIDS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN E; LYMPH NODES; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OVALBUMIN; PEPTIDES;

EID: 84925325900     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.03.013     Document Type: Article

References (47)

1. Arthur J.S., Ley S.C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 2013, 13:679-692.
2. 2-26: reduction of allergic inflammation in the rat. J.Pharmacol. Exp. Ther. 2005, 313:1416-1422.
3. Bilkhu P.S., Wolffsohn J.S., Naroo S.A. Areview of non-pharmacological and pharmacological management of seasonal and perennial allergic conjunctivitis. Cont. Lens Anterior Eye 2012, 35:9-16.
4. Bundoc V.G., Keane-Myers A. IL-10 confers protection from mast cell degranulation in a mouse model of allergic conjunctivitis. Exp. Eye Res. 2007, 85:575-579.
5. Chen J.J., Applebaum D.S., Sun G.S., Pflugfelder S.C. Atopic keratoconjunctivitis: a review. J.Am. Acad. Dermatol. 2014, 70:569-575.
6. Chung S.H., Nam K.H., Kweon M.N. Staphylococcus aureus accelerates an experimental allergic conjunctivitis by toll-like receptor 2-dependent manner. Clin. Immunol. 2009, 131:170-177.
7. Chung Y.W., Oh H.Y., Kim J.Y., Kim J.H., Kim I.Y. Allergen-induced proteolytic cleavage of annexin-1 and activation of cytosolic phospholipase A2 in the lungs of a mouse model of asthma. Proteomics 2004, 4:3328-3334.
8. D'Acquisto F., Perretti M., Flower R.J. Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br. J. Pharmacol. 2008, 155:152-169.
9. da Silva P.S., Girol A.P., Oliani S.M. Mast cells modulate the inflammatory process in endotoxin-induced uveitis. Mol. Vis. 2011, 17:1310-1319.
10. Dalli J., Rosignoli G., Hayhoe R.P., Edelman A., Perretti M. CFTR inhibition provokes an inflammatory response associated with an imbalance of the annexin A1 pathway. Am. J. Pathol. 2010, 177:176-186.
11. Damazo A.S., Yona S., D'Acquisto F., Flower R.J., Oliani S.M., Perretti M. Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am. J. Pathol. 2005, 166:1607-1617.
12. Damazo A.S., Yona S., Flower R.J., Perretti M., Oliani S.M. Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J.Immunol. 2006, 176:4410-4418.
13. Friedlaender M.H. Ocular allergy. Curr. Opin. Allergy Clin. Immunol. 2011, 11:477-482.
14. Fukuda K., Nishida T. Ocular allergic inflammation: interaction between the cornea and conjunctiva. Cornea 2010, 29(Suppl. 1):S62-S67.
15. Fukushima A., Sumi T., Fukuda K., Kumagai N., Nishida T., Ueno H. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis. Int. Arch. Allergy Immunol. 2007, 144:79-84.
16. Galli S.J., Tsai M. IgE and mast cells in allergic disease. Nat. Med. 2012, 18:693-704.
17. Gastardelo T.S., Damazo A.S., Dalli J., Flower R.J., Perretti M., Oliani S.M. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am. J. Pathol. 2009, 174:177-183.
18. Giavina-Bianchi P., Kalil J., Rizzo L.V. Development of an animal model for allergic conjunctivitis: influence of genetic factors and allergen concentration on immune response. Acta Ophthalmol. 2008, 86:670-675.
19. Gil C.D., La M., Perretti M., Oliani S.M. Interaction of human neutrophils with endothelial cells regulates the expression of endogenous proteins annexin 1, galectin-1 and galectin-3. Cell. Biol. Int. 2006, 30:338-344.
20. Girol A.P., Mimura K.K., Drewes C.C., Bolonheis S.M., Solito E., Farsky S.H., Gil C.D., Oliani S.M. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation invivo and invitro. J.Immunol. 2013, 190:5689-5701.
21. Gor D.O., Rose N.R., Greenspan N.S. TH1-TH2: a procrustean paradigm. Nat. Immunol. 2003, 4:503-505.
22. Hannon R., Croxtall J.D., Getting S.J., Roviezzo F., Yona S., Paul-Clark M.J., Gavins F.N., Perretti M., Morris J.F., Buckingham J.C., Flower R.J. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J. 2003, 17:253-255.
23. Lee S.H., Kim D.W., Kim H.R., Woo S.J., Kim S.M., Jo H.S., Jeon S.G., Cho S.W., Park J.H., Won M.H., Park J., Eum W.S., Choi S.Y. Anti-inflammatory effects of Tat-annexin protein on ovalbumin-induced airway inflammation in a mouse model of asthma. Biochem. Biophys. Res. Commun. 2012, 417:1024-1029.
24. Leonardi A., Curnow S.J., Zhan H., Calder V.L. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin. Exp. Allergy 2006, 36:777-784.
25. Li D.Q., Zhang L., Pflugfelder S.C., De Paiva C.S., Zhang X., Zhao G., Zheng X., Su Z., Qu Y. Short ragweed pollen triggers allergic inflammation through toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways. J.Allergy Clin. Immunol. 2011, 128. 1318-1325.e1312.
26. Magone M.T., Chan C.C., Rizzo L.V., Kozhich A.T., Whitcup S.M. Anovel murine model of allergic conjunctivitis. Clin. Immunol. Immunopathol. 1998, 87:75-84.
27. Marback P.M., de Freitas D., Paranhos A., Belfort R. Epidemiological and clinical features of allergic conjunctivitis in a reference center. Arq. Bras. Oftalmol. 2007, 70:312-316.
28. McGhee C.N., Dean S., Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf. 2002, 25:33-55.
29. Mimura K.K., Tedesco R.C., Calabrese K.S., Gil C.D., Oliani S.M. The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis. Mol. Vis. 2012, 18:1583-1593.
30. Ng F.S., Wong K.Y., Guan S.P., Mustafa F.B., Kajiji T.S., Bist P., Biswas S.K., Wong W.S., Lim L.H. Annexin-1-deficient mice exhibit spontaneous airway hyperresponsiveness and exacerbated allergen-specific antibody responses in a mouse model of asthma. Clin. Exp. Allergy 2011, 41:1793-1803.
31. Oliani S.M., Christian H.C., Manston J., Flower R.J., Perretti M. An immunocytochemical and in situ hybridization analysis of annexin 1 expression in rat mast cells: modulation by inflammation and dexamethasone. Lab. Invest. 2000, 80:1429-1438.
32. Oliani S.M., Ciocca G.A., Pimentel T.A., Damazo A.S., Gibbs L., Perretti M. Fluctuation of annexin-A1 positive mast cells in chronic granulomatous inflammation. Inflamm. Res. 2008, 57:450-456.
33. Oliani S.M., Paul-Clark M.J., Christian H.C., Flower R.J., Perretti M. Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am. J. Pathol. 2001, 158:603-615.
34. Pelaia G., Cuda G., Vatrella A., Gallelli L., Caraglia M., Marra M., Abbruzzese A., Caputi M., Maselli R., Costanzo F.S., Marsico S.A. Mitogen-activated protein kinases and asthma. J.Cell. Physiol. 2005, 202:642-653.
35. Pelikan Z. Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa. Mol. Vis. 2013, 19:1453-1470.
36. Pelikan Z. Cytokine profiles in tears accompanying the secondary conjunctival responses induced by nasal allergy. Curr. Eye Res. 2014, 39:120-132.
37. Read R.W., Yu F., Accorinti M., Bodaghi B., Chee S.P., Fardeau C., Goto H., Holland G.N., Kawashima H., Kojima E., Lehoang P., Lemaitre C., Okada A.A., Pivetti-Pezzi P., Secchi A., See R.F., Tabbara K.F., Usui M., Rao N.A. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am. J. Ophthalmol. 2006, 142:119-124.
38. Rosenbaum J.T. Future for biological therapy for uveitis. Curr. Opin. Ophthalmol. 2010, 21:473-477.
39. Shoji J., Sakimoto T., Muromoto K., Inada N., Sawa M., Ra C. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice. Jpn. J. Ophthalmol. 2005, 49:205-210.
40. Skelsey M.E., Mayhew E., Niederkorn J.Y. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 2003, 110:18-29.
41. Sohn J., Kim T.I., Yoon Y.H., Kim J.Y., Kim S.Y. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J.Clin. Invest. 2003, 111:121-128.
42. Stern M.E., Siemasko K., Gao J., Duong A., Beauregard C., Calder V., Niederkorn J.Y. Role of interferon-gamma in a mouse model of allergic conjunctivitis. Invest Ophthalmol. Vis. Sci. 2005, 46:3239-3246.
43. Stern M.E., Siemasko K.F., Niederkorn J.Y. The Th1/Th2 paradigm in ocular allergy. Curr. Opin. Allergy Clin. Immunol. 2005, 5:446-450.
44. Theofilopoulos A.N., Koundouris S., Kono D.H., Lawson B.R. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res. 2001, 3:136-141.
45. 2. Int. Arch. Allergy Immunol. 2011, 154:137-148.
46. Yazid S., Sinniah A., Solito E., Calder V., Flower R.J. Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing annexin A1. PLoS One 2013, 8:e58963.
47. Zheng X., Ma P., de Paiva C.S., Cunningham M.A., Hwang C.S., Pflugfelder S.C., Li D.Q. TSLP and downstream molecules in experimental mouse allergic conjunctivitis. Invest. Ophthalmol. Vis. Sci. 2010, 51:3076-3082.